RudaCure
Incheon, South Korea rudacure.com From their website, Nov 2026
Work here? Claim this listing
About
RudaCure is a Korean drug discovery company focused on membrane proteins, including ion channels and GPCRs, to develop therapeutics for dry eye disease, chronic pain, psoriasis and rare neurological disease. It also provides CRO services related to pharmacology evaluation, in vivo and in vitro assessment, ion-channel screening and ocular-disease animal models. The company is based in Incheon with a Seoul office.
Services
Pharmacology evaluation
Evaluates drug candidates using pharmacology methods as part of CRO services.
In vivo assessment
Conducts in vivo assessment services for drug discovery programs.
In vitro assessment
Conducts in vitro assessment services for drug discovery programs.
Ion-channel screening
Screens compounds for ion-channel activity and selectivity.
Ocular-disease animal models
Uses animal models for ocular-disease research and evaluation.
Capabilities
- Assays and studies
- Patch clamp
- AAV
- In vivo
- Electrophysiology
- High-throughput electrophysiology
- Pharmacology evaluation
4 more
- AI-based molecular prediction
- Structure-based design
- Molecular dynamics simulations
- Ion-channel screening
- Scale and capacity
- 6 sites
- Therapeutic areas
- Dry eye disease
- Chronic pain
- Psoriasis
- Rare neurological disease
- Pain
- Ophthalmology
5 more
- Dermatology
- Veterinary
- Sensory disease
- Inflammatory disease
- Veterinary dry eye
Instruments and platforms
- Patch clamp
Modalities and species
- Modalities
- Viral vector
- Species and models
- Ocular-disease animal models
- TRPV1
- GPCR
- Ion channels
- Dry eye disease model
- Sjögren's syndrome model
Industries served
- Biotech
- Veterinary pharma
Company
- Type
- CRO
- Founded
- 2018
Locations
- Based in
- Incheon, South Korea
- Sites
- Seoul, Korea
- Serves
- Korea, US, Japan, Europe
Contacts
- Phone
- 032-724-9070